SEC Form 4 · accession 0001209191-15-052360
IMMUNOMEDICS INC · IMMU
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Don C Stark
Director
Period of report
Jun 10, 2015
Accepted (ET)
Jun 11, 2015 · 5:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000722830
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 10, 2015 | M | 10,000 | $1.76 | A | 40,450 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F1 | $1.76 | Jun 10, 2015 | M | 10,000 | D | — | Jun 30, 2015 | Common Stock, par value $0.01 per share | 10,000 | 0 | D |
Explanation of responses
- F1The stock options vested over four years at a rate of 25% per year.